We compared this approach with more traditional measures of Braak staging and tau-PET uptake in a temporal meta-ROI.9 We hypothesized that a region-specific analysis of tau-PET abnormality would offer a more useful measure of cognitive impairment than other approaches that rely on tracer uptake in one set of regions across all individuals. This evidence concerns the gene MAPT and Cognitive impairment.